1.3 M ARCO TEÓRICO - CONCEPTUAL
1.3.4 Consecuencias de la violencia de género
1.3.4.1 Consecuencias de la violencia de género en la salud de las mujeres víctimas
Notes to Pro-rata Statements of Income
Sales. Per company sources, the percentage of the total company sales that has been contributed by the Restolax in 2004 is 92.60%. Due to the creation of Restolax Forte, it has decreased to 76% and 69% for 2005 and 2006, respectively.
Cost of Sales. It is estimated that the Cost of Sales for Restolax during 2004 was at 68.85% of sales. It decreased in the years 2005 and 2006 to 61.56% and 60%, respectively.
Gross Profit. Computed by deducting Cost of Sales from Sales
Net Income Before Tax. Computed by subsequently deducting Operating Expenses from the resulting total from Gross Profit.
Provision for Income Tax. In accordance with tax laws pertaining to corporations, this is computed at 32% of Net Income Before Tax
Net Income After Tax. Calculated by deducting Provision for Income
Tax from Net Income Before Tax.
Notes to 2008 Projected Income Statement
Gross Sales. In 2007, the company is expected to have Gross Sales of P24,071,635.90 based on the horizontal analysis of 2006-2007.
Gross Sales is expected to increase by 17% without the benefit of the proposed marketing strategies by the researchers. This will bring 2008 revenues to P28,163,814.00. The incremental sales to be realized in the projected year 2008 = P6,499,341.69 will be realized through the implementation of the following strategies and action plans:
Normal expected increase in sales (10%): P2, 407,164.00
Product Strategy A: Strengthen brand focus and target market Action Plan 1: Improve blister pack and packaging of Restolax Total 2008 annual sales increase due to improved packaging: 2%
Total 2008 annual sales increase in pesos: P 481,433.00
Action Plan 2: Below-the-line campaign
Estimated incremental increase in Gross Sales due to Action Plan 2: 6%
Estimated 2008 annual sales in pesos : P 1,444,298.15
Place Strategy C: Strengthen presence in smaller drugstore chains Action Plan 1: Localized promotions and merchandising improvements
Estimated incremental increase in Gross Sales due to Action Plan 1: 0.5%
Estimated 2008 annual sales in pesos: P120,358.00
Place Strategy D: Enter new distribution channels
Action Plan 1: Tapping sari-sari stores and non-chain convenience stores for distribution
Estimated incremental increase in Gross Sales due to Action Plan 1: 0.5%
Estimated 2008 annual sales in pesos: P120,358.18
Action Plan 2: Opening Vis-Min area through distributorship Action Plan 3: Attaining institutional accounts in Vis-Min area Estimated incremental increase in Gross Sales due to
distribution in Visayas: 4.5%
Estimated 2008 annual sales in pesos for Visayas: P1,083,224.00
Estimated incremental increase in Gross Sales due to distribution in Mindanao: 3.5%
Estimated 2008 annual sales in pesos for Mindanao: P842,507.00
Cost of Sales. As of 2006, the company has two (2) product variants: Restolax and Restolax Forte. In 2006, with these two (2) products the company’s COS is 60%. The researchers propose the introduction of Topical Muscle Pain Reliever, a liniment which is expected to garner 30% of the company’s total sales mix. This liniment will have 36% COS.
Gross Profit. Follows the same 0.58% relationship to gross sales as a vertical relationship of 2006.
Salaries and Wages. Perceived to increase by the projected annual inflation rate of 4.6%
Insurance Expense. Follows the same 0.24% relationship to gross sales as a vertical relationship of 2006.
Rental Expense. Perceived to increase by the projected annual inflation rate of 4.6%
Light and Water. Perceived to increase by the projected annual inflation rate of 4.6%
Gas and Oil. Perceived to increase by the projected annual inflation rate of 4.6%
Postage, Telephone, and Telegraph. Perceived to increase by the projected annual inflation rate of 4.6%
Office Supplies. Perceived to increase by the projected annual inflation rate of 4.6%
SSS and ECC Contribution. Follows a similar vertical relationship of 2.46% of salaries and wages as in 2006.
Philhealth Contribution. Follows a similar vertical relationship of 0.37%of salaries and wages as in 2006.
Pag-ibig Contribution. Follows a similar vertical relationship of 0.81% of salaries and wages as in 2006.
Professional Fee. Perceived to remain constant in 2008.
Marketing Budget. As per the research proponent, a marketing budget for 2008 amounting to P2,901,875 is proposed.
Repairs and Maintenance. Perceived to increase by the projected annual inflation rate of 4.6%
Representation Expenses. Perceived to increase by the projected annual inflation rate of 4.6%
Transportation Expenses. Perceived to increase by the projected annual inflation rate of 4.6%
Dues and Subscription. Perceived to remain constant in 2008.
Employee Benefit. Follows a similar vertical relationship of 15.38% of salaries and wages as in 2006.
13th Month Pay. Follows a similar vertical relationship of 6.05%
of salaries and wages as in 2006.
Miscellaneous Expenses. Perceived to increase by the projected annual inflation rate of 4.6%
Security Expenses. Perceived to increase by the projected annual inflation rate of 4.6%
Donation Expenses. Perceived to remain constant in 2008.
Bonus and Christmas Expenses. Follows a similar vertical relationship of 4.38% of salaries and wages as in 2006.
Depreciation Expenses. Perceived to remain constant in 2008.
Income from Operations. Arrived at by deducting Total Operating Expense from Gross Profit.
Provisions for Income Tax. Computed at 32% of Income from Operations in compliance with prevailing Corporate Tax Rates.
Net Income After Tax. Computed by deducting Provisions for
Income Tax from Income from Operations.
Notes to 2008 Marketing Budget
Advertising Expenses. Includes all items superscripted by the letter a in the preceding Action Plans.
Marketing Collaterals. Includes all items superscripted by the letter b in the preceding Action Plans.
Sample Costs. Includes all items superscripted by the letter c in the preceding Action Plans.
Ad Production and Development. Includes all items superscripted by the letter d in the preceding Action Plans.
Location Fee/Rental. Includes all items superscripted by the letter e in the preceding Action Plans.
Prizes (Restolax Pillows). Includes all items superscripted by the letter f in the preceding Action Plans.
Talent and Professional fees. Includes all items superscripted by the letter g in the preceding Action Plans.
Design - Outsourced Creatives. Includes all items superscripted by the letter h in the preceding Action Plans.
Ex-Deal Costs. Includes all items superscripted by the letter i in the preceding Action Plans.
Permits, etc. Includes all items superscripted by the letter j in the preceding Action Plans.
Market Research. Includes all items superscripted by the letter k in the preceding Action Plans.
Production Costs. Includes all items superscripted by the letter l in the preceding Action Plans.
Contracted Manpower Fees. Includes all items superscripted by the letter m in the preceding Action Plans.
Shipping Fees, Customs, etc. Includes all items superscripted by the letter n in the preceding Action Plans.
APPENDICES
Appendix A
UAI Questionnaire on Muscle-Pain Reliever Industry
MUSCLE-PAIN RELIEVER
I. INTRODUCTION
Good morning/afternoon/evening! We are King del Rosario and Michael Yukong, graduating Marketing Management students of the De La Salle-College of Saint Benilde. We are conducting a survey for our thesis regarding muscle-pain relievers and we would like to have you as our respondent.
Magandang umaga/tanghali/gabi! Ako, si King del Rosario at ang kasama kong si Michael Yukong, ay mga graduating students ng kursong Marketing Management sa De La Salle-College of Saint Benilde.
Gumagawa kami ng survey para sa aming thesis tungkol sa muscle-pain relievers at nais sana namin kayong maging respondent.
Please feel free to answer us with your personal opinion as we go through the survey. Take note that there are no right or wrong answers. Thank you.
Huwag kayong mag-atubiling ibigay ang inyong personal na opinyon sa pagsagot sa aming survey. Wala po ditong tama o maling sagot. Maraming salamat.
II. SCREENING:
1) (If M/F probability):
Who in your household, between the ages of 18 to 60 (per yellow paper’s target market in terms of age), last celebrated his/her birthday?
Sino sa mga kasambahay mo, na may edad na 18 hanggang 60 (ayon sa target market na isinasaad ng yellow paper), ang nagdiwang ng kanyang kaarawan kamakailan lang?
Ask for and interview the last birthday celebrant or mom. Get details on the following:
Hilinging makapanayam ito at kumuha ng mga detalye sa mga sumusunod:
Exact age: _______________
Eksaktong edad
Gender: [ ] M [ ] F Kasarian
SEC: [ ] AB [ ] C [ ] D
2) Do you or any member of your family, relatives or close friends work for a/an:
Nagtatrabaho ka ba o sino mang miyembro ng iyong pamilya, kamag-anak o mga kaibigan sa:
No Yes
Pharmaceutical company? /__/ /__/ - (T by thanking respo)
Advertising agency? /__/ /__/ - (T by thanking respo)
Market research agency? /__/ /__/ - (T by thanking respo)
Media like TV, newspaper,
radio, etc.? /__/ /__/ - (T by thanking respo)
3) Do you use muscle-pain relievers?
Gumagamit ka ba ng muscle-pain relievers?
( ) No ***(Go to Q4)
( ) Yes ***(Got to Q5)
4) Why don’t you use muscle-pain relievers? (SA)
Bakit ka hindi gumagamit ng muscle-pain relievers? (SA)
__________________________________________________________
__
__________________________________________________________
__
Terminate by thanking the respondent for his/her time. (This terminated respondent forms part of the “non-user” group and part of the 200 required respondent base.)
5) How often do you use muscle-pain relievers? (SA)
( ) 5-7 times a week ***(Go to Q7) ( ) 1-4 times a week ***(Go to Q7)
( ) 2-3 times a month ***(Go to Q6)
( ) once a month ***(Go to Q6)
( ) less than once a month ***(Go to Q6) Gaano ka kadalas gumamit ng muscle-pain relievers? (SA) ( ) 5-7 beses sa isang linggo (Dumeretso sa Q7)
( ) 1-4 beses sa isang linggo (Dumeretso sa Q7) ( ) 2-3 beses sa isang buwan (Dumeretso sa Q6)
( ) 1 beses sa isang buwan (Dumeretso sa Q6)
( ) bihira (Dumeretso sa Q6)
6) Why don’t you use muscle-pain relievers more often?
Bakit hindi ka madalas gumamit muscle-pain relievers?
__________________________________________________________
__
__________________________________________________________
__
Terminate by thanking the respondent for his/her time. (This terminated respondent forms part of the “lapser” group and part of the 200 required respondent base.)